GridAI Technologies Corp. - Asset Resilience Ratio
GridAI Technologies Corp. (GRDX) has an Asset Resilience Ratio of 0.52% as of June 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GridAI Technologies Corp. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2015)
This chart shows how GridAI Technologies Corp.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is GridAI Technologies Corp.'s balance sheet.
Liquid Assets Composition Over Time
This chart breaks down GridAI Technologies Corp.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read GridAI Technologies Corp. (GRDX) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $34.11K | 0.52% |
| Total Liquid Assets | $34.11K | 0.52% |
Asset Resilience Insights
- Limited Liquidity: GridAI Technologies Corp. maintains only 0.52% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
GridAI Technologies Corp. Industry Peers by Asset Resilience Ratio
Compare GridAI Technologies Corp.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX |
Biotechnology | 15.95% |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Halozyme Therapeutics Inc
NASDAQ:HALO |
Biotechnology | 12.71% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
Biotechnology | 33.23% |
|
Nanobiotix
NASDAQ:NBTX |
Biotechnology | 4.71% |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
Biotechnology | 65.12% |
Annual Asset Resilience Ratio for GridAI Technologies Corp. (2014–2015)
The table below shows the annual Asset Resilience Ratio data for GridAI Technologies Corp..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2015-12-31 | 0.85% | $56.85K | $6.69 Million | -1.05pp |
| 2014-12-31 | 1.90% | $125.07K | $6.58 Million | -- |
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in … Read more